Decoy Therapeutics Inc. (DCOY) stock
DCOYNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.95+0.05 (+5.37%)
Close on Nov 17, 2026Market cap $622.03KP/E –Yield –
Decoy Therapeutics price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Decoy Therapeutics's price to sales ratio was 186.5× on Jul 29, 2022, against 81.1× a year earlier. Over the last 3 years it ranged from 10.6× to 461.8×, with a median of 80.8×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2022 | Jul 29, 2022 | 186.5× | +105.6 |
| 2021 | Dec 31, 2021 | 80.9× | +35.8 |
| 2020 | Dec 31, 2020 | 45.2× | −20.6 |
| 2019 | Dec 31, 2019 | 65.8× | – |
See a number that looks wrong?